Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction

Percutaneous transluminal coronary angioplasty for primary treatment after acute myocardial infarction has been demonstrated to be superior to thrombolytic therapy with regard to the restoration of normal coronary blood flow 1 and is associated with lower rates of recurrent ischemia, reinfarction, s...

Full description

Saved in:
Bibliographic Details
Published in:The New England journal of medicine Vol. 341; no. 26; pp. 1949 - 1956
Main Authors: Grines, Cindy L, Cox, David A, Stone, Gregg W, Garcia, Eulogio, Mattos, Luiz A, Giambartolomei, Alessandro, Brodie, Bruce R, Madonna, Olivier, Eijgelshoven, Marcel, Lansky, Alexandra J, O'Neill, William W, Morice, Marie-Claude
Format: Journal Article
Language:English
Published: Boston, MA Massachusetts Medical Society 23-12-1999
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Percutaneous transluminal coronary angioplasty for primary treatment after acute myocardial infarction has been demonstrated to be superior to thrombolytic therapy with regard to the restoration of normal coronary blood flow 1 and is associated with lower rates of recurrent ischemia, reinfarction, stroke, and death. 2 – 4 Primary angioplasty has clinical limitations, however. Abrupt closure occurs more often after primary angioplasty for emergency reperfusion than after elective procedures, and in 10 to 15 percent of patients ischemia recurs before hospital discharge. 2 , 5 Routine angiographic follow-up at six months has demonstrated reocclusion of the infarct-related artery in 10 to 15 percent of patients and . . .
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM199912233412601